Breas Medical AB, a leading innovator in the medical technology sector, is headquartered in Sweden (SE) and operates extensively across Europe and beyond. Founded in 1991, the company has established itself within the precision and optical instruments industry, focusing on advanced respiratory care solutions.
Breas Medical is renowned for its cutting-edge products, including ventilators and non-invasive ventilation devices, which are designed to enhance patient comfort and improve clinical outcomes. The company’s commitment to quality and innovation has positioned it as a trusted partner in healthcare, with notable achievements in developing user-friendly technologies that cater to both patients and healthcare professionals.
With a strong market presence, Breas Medical continues to lead the way in respiratory care, striving to meet the evolving needs of patients worldwide.
-5 vs industry average
Breas Medical AB’s score of 22 is lower than 43% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Breas Medical AB?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Breas Medical AB's reported carbon emissions
Breas Medical AB, headquartered in SE and operating within the medical, precision and optical instruments, watches and clocks industry (33), reported total carbon emissions of approximately 19,673,700 kg CO2e for the 2024 reporting year. This comprehensive figure includes emissions across Scope 1, Scope 2, and Scope 3. The breakdown of their emissions includes: * **Scope 1:** Approximately 65,250 kg CO2e, primarily from mobile combustion. * **Scope 2:** Approximately 144,630 kg CO2e, stemming from purchased heat and purchased electricity. * **Scope 3:** The largest contributor, totalling approximately 19,491,960 kg CO2e. Key Scope 3 categories include the use of sold products (approximately 4,277,860 kg CO2e), purchased goods and services (approximately 11,593,000 kg CO2e), and upstream transportation and distribution (approximately 2,464,540 kg CO2e). Breas Medical AB's emissions data is cascaded from its parent organisation, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., as indicated by the CDP source. The company has not publicly disclosed specific reduction targets or SBTi commitments within the provided information.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Breas Medical AB’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Breas Medical AB yet.
Scope 3 top emissions categories
7 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisations
Breas Medical AB
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project